Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOTANIX PHARMACEUTICALS LTD Major Shareholding Notification 2022

Nov 9, 2022

64551_rns_2022-11-09_cd428ab4-8465-42fc-a285-54e93e890eee.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder

To : BOTANIX PHARMACEUTICALS LTD
ACN: 009 109 755
ASX Code: BOT

1. Details of substantial holder

Name: Insignia Financial Ltd ACN: 100 103 722

This notice is given by IOOF Holdings Limited on behalf of itself and its subsidiaries.

The holder became a substantial shareholder on: 07/11/2022

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interest in the scheme that the substantial holder or an associate had a relevant interest in on the date the substantial holder is as follows:

Class of Number of Person's votes Voting Power
securities securities
Ordinary 70,717,484 70,717,484 6.117%

3. Details of present registered holders

The persons registered as holders of the securities are as follows:

Holder Registered Person Nature of Class & Person's
holder of Entitle relevant Number votes
securities d to be interest (Ord)
holder
Pursuant to
section 608 of
Antares Capital Partners Ltd National the Corporations
(ACN 066 081 114) Nominees (NAS) Act 70,717,484 70,717,484

4. Consideration

The consideration paid for each relevant interest and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

2

Date Person Nature Consideration Class &number(ord) Person’svotes
07/11/2022 Antares Capital Partners Ltd(ACN 066 081 114) Placement 4,455,201.49 70,717,484 70,717,484

5. Associates

Name & ACN Nature of association
Not applicable

6. Addresses

The addresses of persons named in this form are as follows:

Addresses Addresses
.
he addresses of persons named in this form ar e as follows:
N ame Address
IO OF Investment Services Ltd Level 1, 800 Bourke StreetDocklands VIC 3008
BOTANIX PHARMACEUTICALS LTD 68 Aberdeen Street, NorthbridgePERTH, WA 6003, AUSTRALIA
Antares Capital Partners Ltd Ground Floor, 105-153 Miller StreetSydney NSW 2000
Nulis Nominees (Australia) Ltd Ground Floor, 105-153 Miller StreetSydney NSW 2000
National Nominees (NAS) Level 1, 800 Bourke StreetDocklands VIC 3008